Know Cancer

or
forgot password
  • cancer clinical trials in portland, OR

  • Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Providence Portland Medical Center

    Trial Locations
    Providence Portland Medical Center
    Providence Saint Vincent Medical Center
    Columbia River Oncology Program
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia
    Oregon Health and Science University
    Portland, Oregon 97201
    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Relapsing Chronic Myelogenous Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer
    ImClone Investigational Site
    Portland, Oregon 97239
    Breast Cancer
    Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer
    Oregon Health & Science University
    Portland, Oregon 97201
    Thyroid Cancer
    To Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
    Kaiser Permanente

    Trial Locations
    Kaiser Permanente
    Northwest Cancer Specialists
    Providence Medical Center
    Prostate Cancer
    Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
    Knight Cancer Institute at Oregon Health and Science University

    Trial Locations
    Knight Cancer Institute at Oregon Health and Science University
    Legacy Emanuel Children's Hospital
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ototoxicity, Ovarian Cancer, Sarcoma
    American Ginseng in Treating Patients With Fatigue Caused by Cancer
    Providence Cancer Center at Providence Portland Medical Center

    Trial Locations
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Adventist Medical Center
    Chronic Myeloproliferative Disorders, Fatigue, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
    Laparoscopic-Assisted Resection or Open Resection in Treating Patients With Stage IIA, Stage IIIA, or Stage IIIB Rectal Cancer
    Providence Cancer Center at Providence Portland Medical Center
    Portland, Oregon 97213-2967
    Colorectal Cancer
    Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer
    Providence Portland Medical Center

    Trial Locations
    Providence Portland Medical Center
    Legacy Good Samaritan Hospital and Medical Center
    Northwest Cancer Specialists-Rose Quarter Cancer Center
    Providence Cancer Center -The Plaza
    Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving Irinotecan
    CCOP - Columbia River Oncology Program
    Portland, Oregon 97225
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Diarrhea
    Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD
    Doernbecher Children's Hospital (OHSU)
    Portland, Oregon 97239
    Graft vs Host Disease, Graft-Versus-Host Disease
    Efficacy and Safety Study of OncoVEXGM-CSF Compared to GM-CSF in Melanoma
    Earle A Chiles Research Institute, Providence Cancer Center
    Portland, Oregon 97213
    Melanoma
    S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
    CCOP - Columbia River Oncology Program

    Trial Locations
    CCOP - Columbia River Oncology Program
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Malignant Mesothelioma
    Neuropsychological and Behavioral Testing in Young Patients With Cancer
    Oregon Health and Science University
    Portland, Oregon 97201
    Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome
    Providence Portland Medical Center

    Trial Locations
    Providence Portland Medical Center
    Oregon Health Science University
    Carcinoid Syndrome
    S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy
    Kaiser Permanente Health Care - Portland

    Trial Locations
    Kaiser Permanente Health Care - Portland
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Adventist Medical Center
    Legacy Good Samaritan Hospital & Comprehensive Cancer Center
    Northwest Cancer Specialists at Rose Quarter Cancer Center
    Breast Cancer, Chemotherapeutic Agent Toxicity, Fatigue, Neuropathy, Neurotoxicity
    Provenge (TM) for the Treatment of Hormone Sensitive Prostate Cancer
    Oregon Health and Sciences University

    Trial Locations
    Oregon Health and Sciences University
    Providence Medical Center
    Prostate Cancer
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Providence Portland Medical Center

    Trial Locations
    Providence Portland Medical Center
    Kaiser Permanente
    Legacy Good Samaritan Hospital and Medical Center
    Providence Saint Vincent Medical Center
    Columbia River Oncology Program
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
    CCOP - Columbia River Oncology Program

    Trial Locations
    CCOP - Columbia River Oncology Program
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer
    Providence Cancer Center at Providence Portland Medical Center

    Trial Locations
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Adventist Medical Center
    Lung Cancer